Chemoinformaics analysis of 2-Deoxy-D-galactose
| Molecular Weight | 164.157 | nRot | 5 |
| Heavy Atom Molecular Weight | 152.061 | nRig | 1 |
| Exact Molecular Weight | 164.068 | nRing | 0 |
| Solubility: LogS | -0.12 | nHRing | 0 |
| Solubility: LogP | -1.976 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 22.0315 |
| nHD | 4 | BPOL | 12.9065 |
| QED | 0.341 |
| Synth | 3.902 |
| Natural Product Likeliness | 2.119 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.932 |
| HIA | 0.133 |
| CACO-2 | -5.249 |
| MDCK | 0.000477196 |
| BBB | 0.161 |
| PPB | 0.223508 |
| VDSS | 0.403 |
| FU | 0.848788 |
| CYP1A2-inh | 0.01 |
| CYP1A2-sub | 0.042 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.218 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.119 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.02 |
| CL | 2.208 |
| T12 | 0.686 |
| hERG | 0.077 |
| Ames | 0.061 |
| ROA | 0.007 |
| SkinSen | 0.563 |
| Carcinogencity | 0.005 |
| EI | 0.965 |
| Respiratory | 0.354 |
| NR-Aromatase | 0.051 |
| Antiviral | No |
| Prediction | 0.92942 |